Provided by Tiger Fintech (Singapore) Pte. Ltd.

GeoVax Labs Inc

1.01
+0.01071.07%
Pre-market: 1.020.0100+0.99%09:10 EDT
Volume:247.01K
Turnover:238.98K
Market Cap:13.98M
PE:-0.21
High:1.01
Open:0.9993
Low:0.9200
Close:0.9993
Loading ...

GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting

NewMediaWire
·
Yesterday

GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater

NewMediaWire
·
25 Apr

GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress

NewMediaWire
·
25 Apr

GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025

NewMediaWire
·
23 Apr

GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations

NewMediaWire
·
22 Apr

GeoVax Labs Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Apr

GeoVax Labs price target lowered to $14 from $18 at D. Boral Capital

TipRanks
·
16 Apr

GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum

NewMediaWire
·
16 Apr

Roth MKM Reaffirms Their Buy Rating on GeoVax Labs (GOVX)

TIPRANKS
·
16 Apr

Analysts Are Bullish on These Healthcare Stocks: GeoVax Labs (GOVX), Tango Therapeutics (TNGX)

TIPRANKS
·
16 Apr

Roth says BARDA stopping funding for GeoVax COVID trial similar to peers

TIPRANKS
·
16 Apr

GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall

MT Newswires Live
·
16 Apr

Crude Oil Moves Lower; Citigroup Posts Upbeat Results

Benzinga
·
16 Apr

GeoVax to Present Clinical Data at Upcoming April Industry Events

NewMediaWire
·
15 Apr

GeoVax Labs price target lowered to $8.50 from $15 at Alliance Global Partners

TIPRANKS
·
15 Apr

Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

GlobeNewswire
·
15 Apr

BRIEF-GeoVax Labs Got Written Notification From Advanced Technology International

Reuters
·
15 Apr

BUZZ-GeoVax tumbles as HHS ends mid-stage COVID vaccine trial

Reuters
·
15 Apr

GeoVax Labs- Notice Indicated That Barda Terminated Contract for Convenience to Government - SEC Filing

THOMSON REUTERS
·
15 Apr

GeoVax Labs- Notice to Stop Work on Phase 2B Study to Evaluate Geo-Cm04s1 Covid-19 Vaccine Trial - SEC Filing

THOMSON REUTERS
·
15 Apr